Background And Objective: Cervical cancer clinical target volume (CTV) outlining and organs at risk segmentation are crucial steps in the diagnosis and treatment of cervical cancer. Manual segmentation is inefficient and subjective, leading to the development of automated or semi-automated methods. However, limitation of image quality, organ motion, and individual differences still pose significant challenges. Apart from numbers of studies on the medical images' segmentation, a comprehensive review within the field is lacking. The purpose of this paper is to comprehensively review the literatures on different types of medical image segmentation regarding cervical cancer and discuss the current level and challenges in segmentation process.
Methods: As of May 31, 2023, we conducted a comprehensive literature search on Google Scholar, PubMed, and Web of Science using the following term combinations: "cervical cancer images", "segmentation", and "outline". The included studies focused on the segmentation of cervical cancer utilizing computed tomography (CT), magnetic resonance (MR), and positron emission tomography (PET) images, with screening for eligibility by two independent investigators.
Key Content And Findings: This paper reviews representative papers on CTV and organs at risk segmentation in cervical cancer and classifies the methods into three categories based on image modalities. The traditional or deep learning methods are comprehensively described. The similarities and differences of related methods are analyzed, and their advantages and limitations are discussed in-depth. We have also included experimental results by using our private datasets to verify the performance of selected methods. The results indicate that the residual module and squeeze-and-excitation blocks module can significantly improve the performance of the model. Additionally, the segmentation method based on improved level set demonstrates better segmentation accuracy than other methods.
Conclusions: The paper provides valuable insights into the current state-of-the-art in cervical cancer CTV outlining and organs at risk segmentation, highlighting areas for future research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11250284 | PMC |
http://dx.doi.org/10.21037/qims-24-369 | DOI Listing |
Front Biosci (Landmark Ed)
December 2024
Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, 200011 Shanghai, China.
Most cervical cancers are related to the persistent infections of high-risk Human Papillomavirus (HPV) infections. Increasing evidence has witnessed the immunosuppressive effectiveness of HPV in the oncogenesis steps and progression steps. Here we review the immune response in HPV-related cervical malignancies and discuss the crosstalk between HPVs and the host immune response.
View Article and Find Full Text PDFJ Inflamm Res
December 2024
Department of Gynecology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400016, People's Republic of China.
Background: Surgery is the best approach to treat endometrial cancer (EC); however, there is currently a deficiency in effective scoring systems for predicting EC recurrence post-surgical resection. This study aims to develop a clinicopathological-inflammatory parameters-based nomogram to accurately predict the postoperative recurrence-free survival (RFS) rate of EC patients.
Methods: A training set containing 1068 patients and an independent validation set consisting of 537 patients were employed in this retrospective study.
Front Med (Lausanne)
December 2024
Department of Pathology, Fujian Maternity and Child Health Hospital College of Clinical Medical for Obstetrics & Gynecology and Pediatrics, Fujian Medical University, Fuzhou, China.
Objective: This study evaluates the effectiveness of endocervical curettage (ECC) in identifying additional cervical cancer and its precursors in women with atypical glandular cells (AGC) cytology.
Methods: We conducted a retrospective analysis of medical records for women referred to colposcopy with AGC cytology between January 2019 and December 2023. The study included 433 women with AGC cytology who underwent both biopsy and ECC.
Front Oncol
December 2024
Department of Radiotherapy Oncology, The Second Affiliated Hospital of Dalian Medical University, Dalian, China.
Cervical cancer (CC) is a common malignant tumour of the female reproductive system that is highly harmful to women's health. The efficacy of traditional surgery, radiotherapy and chemotherapy is limited, especially for recurrent and metastatic CC. With continuous progress in diagnostic and treatment technology, immunotherapy has become a new approach for treating CC and has become a new therapy for recurrent and metastatic CC.
View Article and Find Full Text PDFFront Immunol
December 2024
State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center of Cancer Medicine, Guangzhou, China.
Background: Several clinical trials have shown that immunotherapy plays a pivotal role in the treatment of patients with metastatic synovial sarcoma. Immune-related genes (IRGs) have been demonstrated to predict the immunotherapy response in certain malignant tumours. However, the clinical significance of IRGs in patients with synovial sarcoma (SS) is still unclear.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!